Form 4: Aura Biosciences COO Receives Stock Grant
Insider Transaction (Form 4)
Susan Abu-Absi, Chief Operating Officer of Aura Biosciences, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Grant/award: acquired 134,513 Common Stock on September 1, 2026; holds 134,513 after (Direct).
- Grant/award: acquired 265,487 Stock Option (Right to Buy) on September 1, 2026; holds 265,487 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Susan Abu-Absi — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 134,513 | — | — | 134,513 |
| 2026-09-01 | Grant/award | Stock Option (Right to Buy) | 265,487 | — | — | 265,487 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (134,513 shares) |
| 2026-09-01 | Grant/award (265,487 shares) |
Keywords
insider transaction, Form 4, AURA, Aura Biosciences, Inc., neutral, Susan Abu-Absi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.